CIK 0001590750
- Large accelerated filer
Viridian Therapeutics, Inc.\DE
Sign in to watch- Ticker
- VRDN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 471187261
- Phone
- +1 617-272-4600
- Business address
- 221 CRESCENT STREET, SUITE 103A, WALTHAM, MA, 02453
- Former names
- MIRAGEN THERAPEUTICS, INC., SIGNAL GENETICS, INC., SIGNAL GENETICS LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $348,194
- in 1 filing
Net −$348,194. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 15 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-01 | Kiselak Tomas Director | Grant or award · Stock Option (Right to Buy) | +32,341 | 32,341 | ||
| 2025-07-01 | Kiselak Tomas Director | Grant or award · Stock Option (Right to Buy) | +21,000 | 21,000 | ||
| 2024-06-26 | Kiselak Tomas Director | Grant or award · Stock Option (Right to Buy) | +21,000 | 21,000 | ||
| 2023-06-14 | Kiselak Tomas Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2022-06-08 | Kiselak Tomas Director | Grant or award · Stock Option (Right to Buy) | +12,500 | 12,500 | ||
| 2021-06-03 | Kiselak Tomas Director | Grant or award · Stock Option (Right to Buy) | +12,500 | 12,500 | ||
| 2021-02-04 | Kiselak Tomas Director | Grant or award · Director Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2020-10-27 | Kiselak Tomas Director | Grant or award · Director Stock Option (Right to Buy) | +24,000 | 24,000 |
Page 1 of 1 · 8 trades